|

More articles from Pharma Marketletter
AVI BioPharma submits IND for HCV drug.(Brief Article), July 11, 2005 AstraZeneca's Zactima enters Ph III for NSCLC.(Brief Article), July 11, 2005 Genaera initiates Ph III study of Evozin.(Brief Article), July 11, 2005 Dyax changes DX-88 to subcutaneous form.(Brief Article), July 11, 2005 Novartis buys rights to Arrow's RSV drug.(Brief Article), July 11, 2005
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|